Depression Clinical Trials in Chicago

Showing 181-200 of 229 trials

A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

NCT00555997

This is a study on the effectiveness, tolerability and safety of oral ziprasidone as monotherapy in patients with major depressive disorder (MDD). Outpatients suffering from MDD will be treated with either ziprasidone or placebo for 12 weeks. Hypothesis: There will be a statistically significant difference in the magnitude of response, as measured by a decrease in baseline 17-item Hamilton Depression Rating Scale (HAM-D-17) scores, between the two treatment groups; the reduction in HAM-D-17 scores will be greater in the ziprasidone monotherapy group than in the placebo group.

Major Depressive Disorder

Massachusetts General Hospital120 participantsStarted Mar 2008

Los Angeles, California, United States • Farmington, Connecticut, United States • Norwich, Connecticut, United States +4 more locations

COMPLETEDPhase 32.2 miles

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

NCT00672620

The purpose of this study is to determine the efficacy and safety of vortioxetine, once daily (QD), in adults with major depressive disorder.

Major Depressive Disorder

Takeda611 participantsStarted Apr 2008

Beverly Hills, California, United States • Irvine, California, United States • Santa Ana, California, United States +35 more locations

A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Depression Trials in Other Cities

A Study of Aripiprazole in Patients With Major Depressive Disorder

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Treatment for Chronic Depression

Doula Support for Young Mothers: A Randomized Trial

Thinking Skills for Work in Severe Mental Illness

Primary Care Internet-Based Depression Prevention for Adolescents (CATCH-IT)

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Seroquel in Bipolar Depression Versus SSRI

Pediatric Bipolar Depression

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression

Study of Antidepressants in Parkinson's Disease

Expanding and Testing VA Collaborative Care Models for Depression

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder

Other Conditions in Chicago